likely that the overdose potential of the compound is due to its sympathomimetic effects, as the side effects noted in overdose cases include cardiac arrhythmia and seizure. It also seems that oral consumption is safer than insufflation. Gloria Discerni, 18, died after overdosing on a drug initially believed to be LSD. Authorities learned months later that the drug wasn't LSD but a "designer drug" identified as 5-MeO-AMT. Legal Status Australia 5-MeO-aMT is considered a Schedule 9 prohibited substance in Australia under the Poisons Standard (October 2015). A Schedule 9 substance is a substance which may be abused or misused, the manufacture, possession, sale or use of which should be prohibited by law except when required for medical or scientific research, or for analytical, teaching or training purposes with approval of Commonwealth and/or State or Territory Health Authorities. Sweden Sveriges riksdags health ministry Statens folkhälsoinstitut classified 5-MeO-αMT as "health hazard" under the act Lagen om förbud mot vissa hälsofarliga varor (translated Act on the Prohibition of Certain Goods Dangerous to Health) as of Oct 1, 2004, in their regulation SFS 2004:696 listed as 5-metoxi-alfametyltryptamin (5-MeO-AMT), making it illegal to sell or possess. United Kingdom 5-MeO-αMT was made illegal in the United Kingdom as of 7 January 2015, along with 5-MeO-DALT. This was following the events of 10 June 2014 when the Advisory Council on the Misuse of Drugs recommended that 5-MeO-αMT be scheduled as a class A drug by updating the blanket ban clause on tryptamines. United States 5-MeO-AMT is not scheduled at the federal level in the United States. Florida 5-MeO-AMT is a Schedule I controlled substance in the state of Florida, making it illegal to buy, sell, or possess. See also 5-Chloro-αMT 5-EtO-AMT 5-MeO-AET 5-MeO-DMT 5-MeO-DPT 5-MeO-DiPT AMT References External links DEA forensic journal on 5-MeO-AMT Erowid 5-MeO-AMT vault Lycaeum 5-MeO-AMT page TiHKAL entry 5-MeO-AMT (α,O-DMS) entry in TiHKAL • info Psychedelic tryptamines Monoamine oxidase inhibitors Serotonin-norepinephrine-dopamine releasing agents Serotonin receptor agonists Mexamines Designer drugs